allogeneic large multivalent immunogen breast cancer vaccine
Term · Oncology and biomedicine · MLC-T-ONC-009915
A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.
| Identifier | MLC-T-ONC-009915 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic LMI breast cancer vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009915",
"term": "allogeneic large multivalent immunogen breast cancer vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.",
"synonyms": [
"allogeneic LMI breast cancer vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine/"
}
Record 801 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.